Page 12 - Mobility Management, August 2018

mm beat
Numotion Expands Midwestern Presence
Numotion has expanded its footprint in the Midwestern United States.
In a June 5 news announcement, the ATP provider said it had acquired the rehab division of Midwest Respiratory & Rehab, which has served seating and wheeled mobility clients for the last 10 years, primarily in Iowa and Nebraska.
Numotion CEO Mike Swinford said in the announce- ment, “We are excited about expanding in Nebraska and Iowa. We are always looking for ways to better serve customers and provide them with innovative mobility solutions. Midwest’s reach, coupled with our product and service offerings, provides the disabled community
with the best resources available in the market.” Complex rehab employees from Midwest will join
Numotion’s north central team, the company said. The other segments of Midwest’s business were not included in the Numotion deal.
Mick Hall, VP of Midwest, said, “Midwest is excited about the acquisition of our rehab division by the nation’s largest CRT provider, who we are confident will continue to serve our customers well in Nebraska and Iowa. We are pleased to continue to serve our vent and respiratory customers, as well as continuing our services with hospice and nursing home equipment rental throughout the Midwest.” m
Duchenne MD Registry
Marks 10th Anniversary
The Duchenne Registry, known as “the world’s largest repository of patient-reported data on Duchenne muscular dystrophy,” celebrated its 10th anniversary in June.
The registry (https://www.duchenneregistry.org) currently houses information on 4,200 people from more than 100 countries who have Duchenne or Becker muscular dystrophy, conditions that typically affect males. The registry also includes female carriers.
Parent Project Muscular Dystrophy (PPMD), a non-profit group headquartered in Hackensack, N.J., launched the registry in May 2008.
In a news announcement of the anniversary, PPMD founder Pat Furlong noted advances in treating muscular dystrophy since she founded PPMD in 1994. When the organization began, Furlong said, “The mean age of death was still in the late teens. Since then, we’ve seen a 10- to 15-year increase in life spans, with care optimiza- tion being the biggest reason for this result.”
Pharmaceutical companies developing treatments for muscular dystrophy have used the registry to find candi- dates to participate in clinical trials. So far, about 60 clinical trials have used the registry as a recruitment tool.
10 AUGUST2018|MOBILITYMANAGEMENT
To mark the registry’s milestone anniversary, PPMD said the registry’s Web site has been upgraded with addi- tional tools and functions, including a new dashboard that includes “the medications module, which will be critical in this new era of approved Duchenne therapies.”
The new Web site will still allow families to upload medical records, add information on healthcare providers and family members, and access board-certi- fied genetic counselors who focus on Duchenne MD.
Upcoming functions will include the ability for parents to compare their child’s data with data from other people in the muscular dystrophy community. m
MobilityMgmt.com